Is HUM or TMO cheaper?

On trailing earnings, TMO is cheaper: HUM trades at a 43.50 P/E and TMO at 29.36.

Which has grown faster, HUM or TMO?

Over the past five years, HUM grew revenue faster — HUM at a 11.71% CAGR versus TMO at 6.68%.

Does HUM or TMO pay a bigger dividend?

HUM yields 0.87% and TMO yields 0.33% based on trailing dividends and the latest price.

Is HUM or TMO more profitable?

TMO runs the higher net margin — HUM at 0.82% versus TMO at 15.18%.

Which has been the better investment, HUM or TMO?

Over the past 10-year, TMO delivered the higher annualized total return — HUM at 10.63% versus TMO at 13.30%. Past performance doesn't predict future results.

Humana Inc. (HUM) vs Thermo Fisher Scientific Inc. (TMO)

TMO leads on 12 of 16 compared metrics.

A side-by-side comparison of Humana Inc. and Thermo Fisher Scientific Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 14, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

HUM

Humana Inc.

$48.84B

$406.77HealthcareDelayed quote: Jul 14, 2026, 3:59 PM EDT

TMO

Thermo Fisher Scientific Inc.

$198.47B

$534.07HealthcareDelayed quote: Jul 14, 2026, 4:00 PM EDT

Total return — HUM vs TMO

growth of $100 · dividends reinvested · last 30y

HUM +2887.5%TMO +1731.5%HUM compounded faster

HUM TMO

HUM vs TMO: by the numbers

•TMO is the larger company ($198.47B vs $48.84B market cap).
•TMO trades at the lower earnings multiple (29.36 vs 43.50 P/E).
•TMO converts more revenue to profit (15.18% vs 0.82% net margin).
•HUM grew revenue faster over the past five years (11.71% vs 6.68% CAGR).
•HUM pays the higher dividend yield (0.87% vs 0.33%).

Which is better, HUM or TMO?

Metric tally: HUM 4 · TMO 12

It depends on what you're optimizing for:

ValueTMO(lower P/E)

GrowthHUM(faster 5Y revenue CAGR)

IncomeHUM(higher dividend yield)

QualityTMO(higher ROIC)

Metrics side by side

Valuation

Metric	HUM	TMO
P/E ratio	43.50	29.36●
Forward P/E	45.90	21.49●
P/S ratio	0.36●	4.41
P/B ratio	2.64●	3.84
PEG ratio	—	4.54
EV / EBITDA	26.58	22.71●
FCF yield	2.59%	3.39%●

Profitability

Metric	HUM	TMO
Gross margin	14.01%	39.41%●
Operating margin	1.01%	17.76%●
Net margin	0.82%	15.18%●
ROE	6.08%	13.21%●
ROIC	3.12%	7.58%●

Dividends

Metric	HUM	TMO
Dividend yield	0.87%●	0.33%
Payout ratio	35.87%	9.90%

Growth (annualized)

Metric	HUM	TMO
Revenue CAGR (5Y)	11.71%●	6.68%
EPS CAGR (5Y)	-17.27%	1.99%●
FCF CAGR (5Y)	-17.19%	-0.19%●
Total return CAGR (5Y)	-1.45%	1.18%●

Frequently asked

Which is better, HUM or TMO?: It depends on your goal. value: TMO (lower P/E); growth: HUM (faster 5Y revenue CAGR); income: HUM (higher dividend yield); quality: TMO (higher ROIC). Across all compared metrics, TMO leads 12 to 4.
Is HUM or TMO cheaper?: On trailing earnings, TMO is cheaper: HUM trades at a 43.50 P/E and TMO at 29.36.
Which has grown faster, HUM or TMO?: Over the past five years, HUM grew revenue faster — HUM at a 11.71% CAGR versus TMO at 6.68%.
Does HUM or TMO pay a bigger dividend?: HUM yields 0.87% and TMO yields 0.33% based on trailing dividends and the latest price.
Is HUM or TMO more profitable?: TMO runs the higher net margin — HUM at 0.82% versus TMO at 15.18%.
Which has been the better investment, HUM or TMO?: Over the past 10-year, TMO delivered the higher annualized total return — HUM at 10.63% versus TMO at 13.30%. Past performance doesn't predict future results.

Go deeper

Full HUM analysis Full TMO analysis Interactive comparison tool

Dig into the metrics

Humana P/E ratio Thermo Fisher Scientific P/E ratio Humana dividend yield Thermo Fisher Scientific dividend yield Humana ROE Thermo Fisher Scientific ROE Humana operating margin Thermo Fisher Scientific operating margin Humana revenue growth Thermo Fisher Scientific revenue growth Humana free cash flow Thermo Fisher Scientific free cash flow

Humana & Thermo Fisher Scientific appear in these rankings

Best 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 14, 2026.